NetworkNewsBreaks

ThursdayAug 31, 2017 9:19 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Clinical Study of High Absorption TurboCBD™ Product

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced the world’s first clinical study on human volunteers of cannabidiol (CBD) within Lexaria’s TurboCBD™ product. The study, which aims to evaluate the effects of TurboCBD™ on both cardiovascular health and cognitive function, will have a double-blind and placebo controlled cross-over design measuring effects after a single dose, as well as seven days of daily dosing, in 24 volunteers. “Lexaria is proud to be advancing our collective knowledge of the benefits of CBD specifically showcasing the benefits of…

Continue Reading

WednesdayAug 30, 2017 1:15 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 30, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NBEV 19.24% – News: Expands Marley yerba Mate™ with distribution partners throughout the US FTEK 14.14% – News: Receives multiple APC contracts totaling $6.9M SUMR 6.47% – News: Names new member to board of directors CRME 5.60% – News: Presents new data regarding BRINAVESS at European Society of Cardiology Congress 2017 EVLV 5.21% – News: Agrees to sell WWDP for $13.5M ICAD 3.91% – News: Obtains approval of Xoft Axxent balloon applicators from the…

Continue Reading

WednesdayAug 30, 2017 1:14 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage, Increase PT on FTE Networks, Inc. (FTNW)

SeeThruEquity has updated its coverage and increased its price target to $3.20 on shares of FTE Networks, Inc.’s (OTCQX: FTNW) stock following the company’s recent report of financial results for the second quarter of 2017. FTE completed the acquisition of Benchmark Builders, Inc. in April, which contributed to its reported revenues of $50.2 million for the second quarter, a massive increase compared to $3.2 million for the same period of 2016. In addition to contributing to revenues, the company’s acquisition of Benchmark also expands its service capabilities and almost doubles its sales backlog. For more information, visit www.ftenet.com About FTE…

Continue Reading

WednesdayAug 30, 2017 1:12 pm

NetworkNewsBreaks – Otonomy, Inc. (NASDAQ: OTIC) Misses Primary Endpoint in AVERTS-1 Phase 3 Trial; Shares Hit New 52-Week Low

Shares of Otonomy, Inc. (NASDAQ: OTIC) plummeted 81% to a new year-low of $3.80 this morning, a drastic fall below its previous low of $11.30, as investors reacted to news that the company reported negative results for its AVERTS-1 phase 3 clinical trial of OTIVIDEX in patients with Ménière’s disease. The clinical trial missed the primary endpoint and all key vertigo secondary endpoints. Shares of OTIC now trade in a 52-week range of $3.80-$21.15. “Based on these results, we are immediately suspending all development activities for OTIVIDEX including the ongoing AVERTS-2 trial. In addition, the company is undertaking a review…

Continue Reading

WednesdayAug 30, 2017 10:37 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Pledges Donation to Hurricane Harvey Relief Efforts

EdTech innovator ProBility Media Corp. (OTCQB: PBYA) this morning announced that it has committed a portion of its profits – as realized from its initiative to deliver the American Society of Mechanical Engineers (ASME) Boiler Pressure Vessel Code (BPVC) – to victims that have suffered losses as a result of Hurricane Harvey. The company’s donations will be distributed through the Jewish Federation of Greater Houston. “The Jewish Federations of North America have opened an emergency relief fund to support communities and individuals in Houston, San Antonio, Galveston, Corpus Christi and other areas of Texas that have been hammered by Hurricane Harvey,” Noah…

Continue Reading

WednesdayAug 30, 2017 9:48 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Retains PCAOB-Registered East West Accounting Services, LLC to Initiate Audit

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that it has officially retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm based in South Florida. Moving forward, East West will review and analyze PotNetwork’s recently announced financial results, providing credible verification of the company’s second quarter and year-to-date operating performance. “We believe that the timing for this action is now,” Gary Blum, chief executive officer of PotNetwork Holding, stated in the news release. “In consideration of the amount of momentum built up over the past 6 months, coupled with…

Continue Reading

TuesdayAug 29, 2017 11:49 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 29, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ALPE 8.57% – News: Enters joint research program with Mercedes-Benz Research, Development North America and Princeton University OESX 8.14% – News: Receives award notifications from two long-standing automotive customers WNDW 7.12% – News: Enters agreement with Triview Glass Industries, LLC for the fabrication of SolarWindow™ products MICT 5.88% – News: Enertec Systems 2001 subsidiary receives a $650,000 purchase order EARK 4.92% – News: Issues details regarding its open house on September 27 WRIT 4.76%…

Continue Reading

TuesdayAug 29, 2017 11:47 am

NetworkNewsBreaks – SeeThruEquity Initiates Coverage on Nexeon MedSystems, Inc. (NXNN)

SeeThruEquity has initiated coverage and a price target of $2.40 on shares of Nexeon MedSystems, Inc.’s (OTCQB: NXNN) stock. The analyst noted that there are several potential upcoming catalysts for Nexeon, such as the company’s capital raise in the form of issuing a $3 million private placement with price protection and 50% warrant coverage. Additionally, the company plans to commence commercial activities in the second quarter of 2018 for its lead product, NNS, a neurostimulation and recording platform for deep brain stimulation (DBS) that has previously received a CE Mark. The development stage medical device company believes NNS has the…

Continue Reading

TuesdayAug 29, 2017 11:45 am

NetworkNewsBreaks – LiNiu Technology Group (NASDAQ: LINU) Shares Soar on Strategic Cooperation Agreement with Shou Guang Agriculture Logistic Park

LiNiu Technology Group (NASDAQ: LINU) shares are up 73% after the company this morning said it has signed a strategic cooperation agreement with Shou Guang Agriculture Logistic Park ("SGALP"), a company approved by the China National Development and Reform Commission and one of the largest vegetable distribution, pricing, information exchanges and logistic centers throughout Asia. Per the agreement, the companies will collaborate regarding product offerings, information resources, consumers, management of the logistic park and more. Additionally, Guangzhou LiNiu will provide SGALP with access to internet sales channels through its LiNiuYang trading platform, while SGALP permits Guangzhou LiNiu access to its…

Continue Reading

TuesdayAug 29, 2017 11:41 am

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Files Annamycin IND with FDA for Acute Myeloid Leukemia

Shares of Moleculin Biotech (NASDAQ: MBRX) are trading 7% higher this morning following the company’s news that it has filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) to study Annamycin in the treatment of relapsed or refractory acute myeloid leukemia (AML). The company expects the FDA will allow the IND to go into effect, which normally occurs within 30 days and would permit Moleculin to begin additional clinical trials of Annamycin. If the IND goes into effect as the company anticipates, it intends to begin clinical trials in the fourth quarter of 2017. "Now that we…

Continue Reading